Cargando…

Pan-cancer landscape of CENPO and its underlying mechanism in LUAD

BACKGROUND: Centromere protein O (CENPO) is a newly discovered constitutive centromeric protein, associated with cell death. However, little is known about how CENPO expression is associated with human cancers or immune infiltration. Here, we assessed the function of CENPO in pan-cancer and further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shi, Tongdong, Hu, Zaoxiu, Tian, Li, Yang, Yanlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105544/ https://www.ncbi.nlm.nih.gov/pubmed/37061713 http://dx.doi.org/10.1186/s12931-023-02408-3

Ejemplares similares

Advances in lung adenocarcinoma: A novel perspective on prognoses and immune responses of CENPO as an oncogenic superenhancer
por: Shi, Tongdong, et al.
Publicado: (2023)

Prognostic and immune infiltrative biomarkers of CENPO in pan–cancer and its relationship with lung adenocarcinoma cell proliferation and metastasis
por: Wang, Yuanbiao, et al.
Publicado: (2023)

Linc00996 is a favorable prognostic factor in LUAD: Results from bioinformatics analysis and experimental validation
por: Shen, Zhenghai, et al.
Publicado: (2022)

CENPO expression regulates gastric cancer cell proliferation and is associated with poor patient prognosis
por: Cao, Yi, et al.
Publicado: (2019)

CENPO regulated proliferation and apoptosis of colorectal cancer in a p53-dependent manner
por: Liu, Zhicheng, et al.
Publicado: (2022)

CENPO is Associated with Immune Cell Infiltration and is a Potential Diagnostic and Prognostic Marker for Hepatocellular Carcinoma
por: He, Kun, et al.
Publicado: (2022)

NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

The prognostic value of cyclooxygenase-2 expression in patients with esophageal cancer: evidence from a meta-analysis
por: Hu, Zaoxiu, et al.
Publicado: (2017)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

MCM4 acts as a biomarker for LUAD prognosis
por: Tan, Yue, et al.
Publicado: (2023)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

Pan-cancer Landscape of the RUNX Protein Family Reveals their Potential as Carcinogenic Biomarkers and the Mechanisms Underlying their Action
por: Pan, Shen, et al.
Publicado: (2022)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
por: Feng, Hai-Ming, et al.
Publicado: (2023)

STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment
por: Li, Yadong, et al.
Publicado: (2023)

Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China
por: Yang, Yanlong, et al.
Publicado: (2018)

The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD
por: Che, Yinggang, et al.
Publicado: (2022)

The pan-cancer pathological regulatory landscape
por: Falco, Matias M., et al.
Publicado: (2016)

HNRNPK/CLCN3 axis facilitates the progression of LUAD through CAF-tumor interaction
por: Li, Yixin, et al.
Publicado: (2022)

A radiomics nomogram prediction for survival of patients with “driver gene-negative” lung adenocarcinomas (LUAD)
por: Guo, Qi-Kun, et al.
Publicado: (2023)

Comparative immunological landscape between pre- and early-stage LUAD manifested as ground-glass nodules revealed by scRNA and scTCR integrated analysis
por: Wang, Ziqi, et al.
Publicado: (2023)

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Characterization of SHCBP1 to prognosis and immunological landscape in pan-cancer: novel insights to biomarker and therapeutic targets
por: Jiang, Fei, et al.
Publicado: (2023)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
por: Yu, Weina, et al.
Publicado: (2022)

MicroRNA expression profiling of lung adenocarcinoma in Xuanwei, China: A preliminary study
por: Hu, Zaoxiu, et al.
Publicado: (2019)

Immunogenomic pan-cancer landscape reveals immune escape mechanisms and immunoediting histories
por: Mizuno, Shinichi, et al.
Publicado: (2021)

Pan-cancer landscape of homologous recombination deficiency
por: Nguyen, Luan, et al.
Publicado: (2020)

Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers
por: Chen, Mengzhu, et al.
Publicado: (2016)

Pan-cancer landscape of immunology PIWI-interacting RNAs
por: Wan, Dongyi, et al.
Publicado: (2023)

Identification of potential diagnostic and prognostic biomarkers for LUAD based on TCGA and GEO databases
por: Zheng, Qiangqiang, et al.
Publicado: (2021)

Identification and Validation of Long Non-Coding RNA LCIIAR as a Biomarker in LUAD
por: Ren, Wenjun, et al.
Publicado: (2022)

A super pan-genomic landscape of rice
por: Shang, Lianguang, et al.
Publicado: (2022)

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
por: Zhang, Yuwei, et al.
Publicado: (2020)

Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)
por: Zhang, Jieru, et al.
Publicado: (2020)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms
por: Zhou, Ping, et al.
Publicado: (2023)

Comprehensive Landscape of RRM2 with Immune Infiltration in Pan-Cancer
por: Zhou, Zijian, et al.
Publicado: (2022)

AQP3‐mediated H(2)O(2) uptake inhibits LUAD autophagy by inactivating PTEN
por: Wang, Yawei, et al.
Publicado: (2021)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD
por: Tian, Baorui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4180va4qeact5634b83aumjtde